Cytotoxicity and modes of action of five Cameroonian medicinal plants against multi-factorial drug resistance of tumor cells

Journal of Ethnopharmacology

Volumn 153, Issue 1, 2014, Pages 207-219

  Kuete, Victor ^a,b   Tankeo, Simplice B ^b   Saeed, Mohamed E M ^a   Wiench, Benjamin ^a   Tane, Pierre ^b   Efferth, Thomas ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF DSCHANG   (Cameroon)

Author keywords

Apoptosis; Beilschmiedia acuta; Cytotoxicity; Microarrays; Mode of action; Polyscias fulva

Indexed keywords

ALKALOID; ALPHA HEDERIN; ANTHOCYANIN; ANTHRAQUINONE DERIVATIVE; ANTINEOPLASTIC AGENT; BEILSCHMIEDIA ACUTA EXTRACT; BREAST CANCER RESISTANCE PROTEIN; CYTOTOXIC AGENT; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FLAVONOID; GLYCOPROTEIN; LUPEOL; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; PHENOL DERIVATIVE; PLANT EXTRACT; POLYSCIA FULVA EXTRACT; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SAPONIN; TRITERPENE; UNCLASSIFIED DRUG; VINBLASTINE;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BARK; BEILSCHMIEDIA ACUTA; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CLAUSENA; CLUSTER ANALYSIS; DRUG CYTOTOXICITY; DRUG SCREENING; FAGARA TESSMANNII; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GROWTH; HUMAN; HUMAN CELL; IC 50; MEDICINAL PLANT; MITOCHONDRIAL MEMBRANE POTENTIAL; MULTIDRUG RESISTANCE; NEWBOULDIA; NEWBOULDIA LAEVIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYSCIA FULVA; POLYSCIAS FULVA; RESAZURIN ASSAY; TUMOR CELL; TUMOR SUPPRESSOR GENE; CAMEROON; CELL CYCLE CHECKPOINT; CHEMISTRY; DRUG EFFECTS; DRUG RESISTANCE; IC50; NEOPLASMS; PATHOLOGY; TUMOR CELL LINE;

BEILSCHMIEDIA; CLAUSENA ANISATA; FAGARA; NEWBOULDIA LAEVIS; POLYSCIAS FULVA;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CAMEROON; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; HUMANS; INHIBITORY CONCENTRATION 50; MEMBRANE POTENTIAL, MITOCHONDRIAL; NEOPLASMS; PLANT EXTRACTS; PLANTS, MEDICINAL;

EID: 84897107663     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2014.02.025     Document Type: Article

References (87)

1. A.M. Abukhdeir, and B.H. Park P21 and p27: roles in carcinogenesis and drug resistance Expert Rev. Mol. Med. 10 2008 e19
2. S. Adesina The Nigerian zanthoxylum; chemical and biological values Afr. J. Tradit. Comp. Altern. Med. 2 2005 282 301
3. S.K. Adesinan, and E. EI The isolation and identification of anticonvulsant agents from Clausena anisata and Afraegle paniculata Fitoterapia 53 1982 63 66
4. M.C. Alley, D.A. Scudiero, A. Monks, M.L. Hursey, M.J. Czerwinski, D.L. Fine, B.J. Abbott, J.G. Mayo, R.H. Shoemaker, and M.R. Boyd Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay Cancer Res. 48 1988 589 601
5. A. Azzariti, L. Porcelli, A.E. Quatrale, N. Silvestris, and A. Paradiso The coordinated role of CYP450 enzymes and P-gp in determining cancer resistance to chemotherapy Curr. Drug Metab. 12 2011 713 721
6. D.A. Bass, J.W. Parce, L.R. Dechatelet, P. Szejda, M.C. Seeds, and M. Thomas Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation J. Immunol. 130 1983 1910 1917
7. E. Bedir, N.J. Toyang, I.A. Khan, L.A. Walker, and A.M. Clark A new dammarane-type triterpene glycoside from Polyscias fulva J. Nat. Prod. 64 2001 95 97
8. Z. Binkhathlan, and A. Lavasanifar P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives Curr. Cancer Drug Targets 13 2013 326 346
9. I.H. Bowen, B.P. Jackson, and H.M. Motawe An investigation of the stem bark of Bersama abyssinica Planta Med. 51 1985 483 487
10. P. Bragado, A. Armesilla, A. Silva, and A. Porras Apoptosis by cisplatin requires p53 mediated p38alpha MAPK activation through ROS generation Apoptosis 12 2007 1733 1742
11. F. Bunz, P.M. Hwang, C. Torrance, T. Waldman, Y. Zhang, L. Dillehay, J. Williams, C. Lengauer, K.W. Kinzler, and B. Vogelstein Disruption of p53 in human cancer cells alters the responses to therapeutic agents J. Clin. Invest. 104 1999 263 269
12. J.A. Bush, and G. Li Cancer chemoresistance: the relationship between p53 and multidrug transporters Int. J. Cancer 98 2002 323 330
13. Y.H. Choi, and A.M. Yu ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development Curr. Pharm. Des. 20 2014 793 807
14. G.A. Cordell, C.W. Beecher, and J.M. Pezzut Can ethnopharmacology contribute to development of new anti-cancer? J. Ethnopharmacol. 32 1991 117 133
15. A. Cossarizza, R. Ferraresi, L. Troiano, E. Roat, L. Gibellini, L. Bertoncelli, M. Nasi, and M. Pinti Simultaneous analysis of reactive oxygen species and reduced glutathione content in living cells by polychromatic flow cytometry Nat. Protoc. 4 2009 1790 1797
16. C. Dandjesso, J. Klotoé, T. Dougnon, J. Sègbo, J. Atègbo, F. Gbaguidi, L. Fah, B. Fanou, F. Loko, and K. Dramane Phytochemistry and hemostatic properties of some medicinal plants sold as anti-hemorrhagic in Cotonou markets (Benin) Indian J. Sci. Technol. 5 2012 3105 3109
17. L.A. Doyle, W. Yang, L.V. Abruzzo, T. Krogmann, Y. Gao, A.K. Rishi, and D.D. Ross A multidrug resistance transporter from human MCF-7 breast cancer cells Proc. Nat. Acad. Sci. U.S.A. 95 1998 15665 15670
18. T. Efferth The human ATP-binding cassette transporter genes: from the bench to the bedside Curr. Mol. Med. 1 2001 45 65
19. T. Efferth Natural products as inhibitors of epidermal growth factor receptor Forum Immunopathol. Dis. Ther. 2 2011 281 301
20. T. Efferth, U. Fabry, and R. Osieka Apoptosis and resistance to daunorubicin in human leukemic cells Leukemia 11 1997 1180 1186
21. T. Efferth, E. Gebhart, D.D. Ross, and A. Sauerbrey Identification of gene expression profiles predicting tumor cell response to l-Alanosine Biochem. Pharmacol. 66 2003 613 621
22. T. Efferth, and R. Grassmann Impact of viral oncogenesis on responses to anti-cancer drugs and irradiation Crit. Rev. Oncogenesis 11 2000 165 187
23. T. Efferth, and H. Greten Autophagy by natural products in cancer cells Biochem. Anal. Biochem. 1 2012 8
24. T. Efferth, and E. Koch Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy Curr. Drug Targets 12 2011 122 132
25. T. Efferth, V.B. Konkimalla, Y.F. Wang, A. Sauerbrey, S. Meinhardt, F. Zintl, J. Mattern, and M. Volm Prediction of broad spectrum resistance of tumors towards anticancer drugs Clin. Cancer Res. 14 2008 2405 2412
26. T. Efferth, H. Lohrke, and M. Volm Reciprocal correlation between expression of P-glycoprotein and accumulation of rhodamine 123 in human tumors Anticancer Res. 9 1989 1633 1637
27. T. Efferth, J. Mattern, and M. Volm Immunohistochemical detection of P glycoprotein, glutathione S transferase and DNA topoisomerase II in human tumors Oncology 49 1992 368 375
28. T. Efferth, A. Sauerbrey, A. Olbrich, E. Gebhart, P. Rauch, H.O. Weber, J.G. Hengstler, M.E. Halatsch, M. Volm, K.D. Tew, D.D. Ross, and J.O. Funk Molecular modes of action of artesunate in tumor cell lines Mol. Pharmacol. 64 2003 382 394
29. T. Efferth, and M. Volm Antibody-directed therapy of multidrug-resistant tumor cells Med. Oncol. Tumor Pharmacother. 9 1992 11 19
30. T. Efferth, and M. Volm Reversal of doxorubicin-resistance in sarcoma 180 tumor cells by inhibition of different resistance mechanisms Cancer Lett. 70 1993 197 202
31. T. Eichhorn, and T. Efferth P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs J. Ethnopharmacol. 141 2012 557 570
32. K.O. Eyong, K. Krohn, H. Hussain, G.N. Folefoc, A.E. Nkengfack, B. Schulz, and Q. Hu Newbouldiaquinone and newbouldiamide: a new naphthoquinone-Anthraquinone coupled pigment and a new ceramide from Newbouldia laevis Chem. Pharm. Bull. (Tokyo) 53 2005 616 619
33. D., WT, N. Focho, and B. Fonge Medicinal plants of Aguambu - Bamumbu in the Lebialem highlands, southwest province of Cameroon Afr. J. Pharm. Pharmacol. 3 2009 1 13
34. S. Gafner, J. Wolfender, M. Nianga, H. Stoeckli-Evans, and K. Hostettmann Antifungal and antibacterial naphtoquinones from Newbouldia laevis roots Phytochemistry 42 1996 1315 1320
35. M.M. Gottesman, and V. Ling The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research FEBS Lett. 580 2006 998 1009
36. J. Harbone Phytochemical Methods: A Guide to Modern Techniques of Plant Analysis 1973 Chapman & Hall London
37. A. Hutchings, A. Scott, G. Lewis, and A. Cunningham Zulu Medicinal Plants 1996 Natal University Press Pietermaritzburg
38. M.M. Gottesman Mechanisms of cancer drug resistance Ann. Rev. Med. 53 2002 615 627
39. C. Ito, M. Itoigawa, K. Aizawa, K. Yoshida, N. Ruangrungsi, and H. Furukawa Gamma-lactone carbazoles from Clausena anisata J. Nat. Prod. 72 2009 1202 1204
40. P. Jeruto, C. Lukhoba, G. Ouma, D. Otieno, and C. Mutai Herbal treatments in Aldai and Kaptumo divisions in Nandi district, Rift valley province, Kenya Afr. J. Tradit. Comp. Altern. Med. 5 2007 103 105
41. S. Knappskog, and P.E. Lonning P53 and its molecular basis to chemoresistance in breast cancer Expert Opin. Ther. Targets 16 Suppl 1 2012 S23 30
42. V.B. Konkimalla, J.A. McCubrey, and T. Efferth The role of downstream signaling pathways of the epidermal growth factor receptor for Artesunates activity in cancer cells Curr. Cancer Drug Targets 9 2009 72 80
43. V. Kuete, and T. Efferth Cameroonian medicinal plants: pharmacology and derived natural products Front. Pharmacol. 1 2010 123
44. V. Kuete, and T. Efferth Pharmacogenomics of Cameroonian traditional herbal medicine for cancer therapy J. Ethnopharmacol. 137 2011 752 766
45. V. Kuete, T. Eichhorn, B. Wiench, B. Krusche, and T. Efferth Cytotoxicity, anti-Angiogenic, apoptotic effects and transcript profiling of a naturally occurring naphthyl butenone, guieranone A Cell Div. 7 2012 16
46. V. Kuete, A.T. Mbaveng, M. Tsaffack, V.P. Beng, F.X. Etoa, A.E. Nkengfack, J.J. Meyer, and N. Lall Antitumor, antioxidant and antimicrobial activities of Bersama engleriana (Melianthaceae) J. Ethnopharmacol. 115 2008 494 501
47. V. Kuete, P.D. Tchakam, B. Wiench, B. Ngameni, H.K. Wabo, M.F. Tala, M.L. Moungang, B.T. Ngadjui, T. Murayama, and T. Efferth Cytotoxicity and modes of action of four naturally occuring benzophenones: 2,2,5,6- tetrahydroxybenzophenone, guttiferone E, isogarcinol and isoxanthochymol Phytomedicine 20 2013 528 536
48. V. Kuete, H.K. Wabo, K.O. Eyong, M.T. Feussi, B. Wiench, B. Krusche, P. Tane, G.N. Folefoc, and T. Efferth Anticancer activities of six selected natural compounds of some Cameroonian medicinal plants PLoS One 6 2011 e21762
49. S.M. Kupchan, J.L. Moniot, C.W. Sigel, and R.J. Hemingway Tumor inhibitors. LXV. Bersenogenin, berscillogenin, and 3-epiberscillogenin, three new cytotoxic bufadienolides from Bersama abyssinica J. Org. Chem. 36 1971 2611 2616
50. D. Lai, S. Visser-Grieve, and X. Yang Tumour suppressor genes in chemotherapeutic drug response Biosci. Rep. 32 2012 361 374
51. L. Lambert, and K. Keyomarsi Cell cycle deregulation in breast cancer: insurmountable chemoresistance or Achilles heel? Adv. Exp. Med. Biol. 608 2007 52 69
52. Y.S. Lee, S. Yoon, M.S. Park, J.H. Kim, J.H. Lee, and C.W. Song Influence of p53 expression on sensitivity of cancer cells to bleomycin J. Biochem. Mol. Toxicol. 24 2010 260 269
53. F. Leteurtre, G. Kohlhagen, K.D. Paull, and Y. Pommier Topoisomerase II inhibition and cytotoxicity of the anthrapyrazoles DuP 937 and DuP 941 (Losoxantrone) in the National Cancer Institute preclinical antitumor drug discovery screen J. Nat. Cancer Inst. 86 1994 1239 1244
54. J.S. Long, and K.M. Ryan New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy Oncogene 31 2012 5045 5060
55. S.W. Lowe Cancer therapy and p53 Curr. Opin. Oncol. 7 1995 547 553
56. T.J. Mabry, and A. Ulubelen Chemistry and utilization of phenylpropanoids including flavonoids, coumarins, and lignans J. Agric. Food Chem. 28 1980 188 195
57. S. Marchetti, D. Pluim, M. van Eijndhoven, O. van Tellingen, R. Mazzanti, J.H. Beijnen, and J.H. Schellens Effect of the drug transporters ABCG2, Abcg2, ABCB1 and ABCC2 on the disposition, brain accumulation and myelotoxicity of the aurora kinase B inhibitor barasertib and its more active form barasertib-hydroxy-QPA Invest. New Drugs 31 2013 1125 1135
58. M. Martinez-Rivera, and Z.H. Siddik Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53 Biochem. Pharmacol. 83 2012 1049 1062
59. L.M. Mbaze, H.M. Poumale, J.D. Wansi, J.A. Lado, S.N. Khan, M.C. Iqbal, B.T. Ngadjui, and H. Laatsch alpha-Glucosidase inhibitory pentacyclic triterpenes from the stem bark of Fagara tessmannii (Rutaceae) Phytochemistry 68 2007 591 595
60. M. Nagane, A. Levitzki, A. Gazit, W.K. Cavenee, and H.J. Huang Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases Proc. Nat. Acad. Sci. 95 1998 5724 5729
61. T. Nakanishi, and D.D. Ross Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression Chin. J. Cancer 31 2012 73 99
62. K. Natarajan, Y. Xie, M.R. Baer, and D.D. Ross Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance Biochem. Pharmacol. 83 2012 1084 1103
63. R.R. Nelson In-vitro activities of five plant essential oils against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium J. Antimicrob. Chemother. 40 1997 305 306
64. B. Ngadjui, S. Mouncherou, J. Ayafor, B. Sondengam, and F. Tillequin Geranyl coumarins from Clausena anisata Phytochemistry 30 1991 2809 2811
65. F.N. Njayou, P.F. Moundipa, A.N. Tchana, B.T. Ngadjui, and F.M. Tchouanguep Inhibition of microsomal lipid peroxidation and protein oxidation by extracts from plants used in Bamun folk medicine (Cameroon) against hepatitis Afr. J. Tradit. Comp. Altern. Med. 5 2008 278 289
66. J. OBrien, I. Wilson, T. Orton, and F. Pognan Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity Eur. J. Biochem. 267 2000 5421 5426
67. J.A. Ojewole Hypoglycaemic effect of Clausena anisata (Willd) Hook methanolic root extract in rats J. Ethnopharmacol. 81 2002 231 237
68. K.D. Paull, R.H. Shoemaker, L. Hodes, A. Monks, D.A. Scudiero, L. Rubinstein, J. Plowman, and M.R. Boyd Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm J. Nat. Cancer Inst. 81 1989 1088 1092
69. J. Popoca, A. Aguilar, D. Alonso, and M.L. Villarreal Cytotoxic activity of selected plants used as antitumorals in Mexican traditional medicine J. Ethnopharmacol. 59 1998 173 177
70. L.V. Rubinstein, R.H. Shoemaker, K.D. Paull, R.M. Simon, S. Tosini, P. Skehan, D.A. Scudiero, A. Monks, and M.R. Boyd Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines J. Nat. Cancer Inst. 82 1990 1113 1118
71. S.A. Santos, and A. Paulo Small molecule inhibitors of multidrug resistance gene (MDR1) expression: preclinical evaluation and mechanisms of action Curr. Cancer Drug Targets 13 2013 814 828
72. A. Sau, F. Pellizzari Tregno, F. Valentino, G. Federici, and A.M. Caccuri Glutathione transferases and development of new principles to overcome drug resistance Arch. Biochem. Biophys. 500 2010 116 122
73. T.J. Sayers Targeting the extrinsic apoptosis signaling pathway for cancer therapy Cancer Immunol. Immunother. 60 2011 1173 1180
74. U. Scherf, D.T. Ross, M. Waltham, L.H. Smith, J.K. Lee, L. Tanabe, K.W. Kohn, W.C. Reinhold, T.G. Myers, D.T. Andrews, D.A. Scudiero, M.B. Eisen, E.A. Sausville, Y. Pommier, D. Botstein, P.O. Brown, and J.N. Weinstein A gene expression database for the molecular pharmacology of cancer Nat. Genet. 24 2000 236 244
75. A. Schrattenholz, K. Groebe, and V. Soskic Systems biology approaches and tools for analysis of interactomes and multi-target drugs Methods Mol. Biol. 662 2010 29 58
76. A. Senthilkumar, and V. Venkatesalu Phytochemical analysis and antibacterial activity of the essential oil of Clausena anisata (Willd.) Hook. F. ex Benth Int. J. Integr. Biol. 5 2009 116 120
77. K. Shien, S. Toyooka, H. Yamamoto, J. Soh, M. Jida, K.L. Thu, S. Hashida, Y. Maki, E. Ichihara, H. Asano, K. Tsukuda, N. Takigawa, K. Kiura, A.F. Gazdar, W.L. Lam, and S. Miyoshi Acquired resistance to EGFR inhibitors is associated with a manifestation of stem cell-like properties in cancer cells Cancer Res. 73 2013 3051 3061
78. S. Singh, A.R. Khan, and A.K. Gupta Role of glutathione in cancer pathophysiology and therapeutic interventions J. Exp. Ther. Oncol. 9 2012 303 316
79. P. Sonneveld, and E. Wiemer Assays for the analysis of P-glycoprotein in acute myeloid leukemia and CD34 subsets of AML blasts Leukemia 11 1997 1160 1165
80. J.E. Staunton, D.K. Slonim, H.A. Coller, P. Tamayo, M.J. Angelo, J. Park, U. Scherf, J.K. Lee, W.O. Reinhold, J.N. Weinstein, J.P. Mesirov, E.S. Lander, and T.R. Golub Chemosensitivity prediction by transcriptional profiling Proc. Nat. Acad. Sci. U.S.A. 98 2001 10787 10792
81. M. Suffness, and J. Pezzuto Assays Related to Cancer Drug Discovery 1990 Academic Press London
82. J.N. Tshibangu, K. Chifundera, R. Kaminsky, A.D. Wright, and G.M. Konig Screening of African medicinal plants for antimicrobial and enzyme inhibitory activity J. Ethnopharmacol. 80 2002 25 35
83. H. Usman, and J.C. Osuji Phytochemical and in vitro antimicrobial assay of the leaf extract of Newbouldia laevis Afr. J. Tradit. Comp. Altern. Med. 4 2007 476 480
84. M. Volm, T. Efferth, and J. Mattern Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations Anticancer Res. 12 1992 11 20
85. M. Volm, M. Kastel, J. Mattern, and T. Efferth Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas Cancer 71 1993 3981 3987
86. M. Volm, R. Koomagi, J. Mattern, and T. Efferth Expression profile of genes in non-small cell lung carcinomas from long-term surviving patients Clin. Cancer Res. 8 2002 1843 1848
87. S. Wöll, S. Kim, and T. Efferth Animal plant warfare and secondary metabolite evolution Nat. Prod. Bioprospect. 3 2013 1 7